Print

PREVAIL Study: A Genetic Education and Genetic Testing Study for African American Men with Prostate Cancer or with a Strong Family History of Cancer

https://www.facingourrisk.org/research-clinical-trials/study/351/prevail-study-a-genetic-education-and-genetic-testing-study-for-african-american-men-with-prostate-cancer-or-with-a-strong-family-history-of-cancer

Surveys, Registries, Interviews
Study for African American men with prostate cancer or with a strong family history of cancer

Study Contact Information:

Study Coordinators:

Laura Gross laura.gross@yale.edu

Liz Perrotti liz.perrotti@yale.edu (203) 737-5250


The purpose of the PREVAIL study is to evaluate a genetic education video that will deliver information about genetic testing for African American men in a relatable way and increase access to genetic testing. African American men with prostate cancer or with a strong family history of cancer may be eligible for the study. Participants can choose to view the video or see a genetic counselor before making a decision for genetic testing. The entire study can be completed remotely for participants from specific states. The goals of the study are to ensure that videos are an effective way to deliver genetic information to African American males, help with decision-making for prostate cancer genetic testing, and ultimately improve access to genetic testing.

Your participation in the study will involve:

To get started with determining your eligibility for the study, please scan the QR code or visit https://redcap.link/PREVAIL

 

 

 

Lead Researcher: 

Veda Giri, MD
Yale Cancer Center


This Study is Open To:

African American men with prostate cancer, or with a strong family history of cancer, who live in the following states may be eligible to participate:

This Study is Not Open To:

Men who do not live in any of the above states or who have had prior genetic counseling or genetic testing for inherited cancer risk are not eligible to participate.


About FORCE

FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.